Search

Your search keyword '"Fazal L"' showing total 97 results

Search Constraints

Start Over You searched for: Author "Fazal L" Remove constraint Author: "Fazal L"
97 results on '"Fazal L"'

Search Results

8. Combined inhibition of SHP2 and ERK enhances anti-tumour effects in preclinical models

17. Alternative Ways to Die5Epac1 deletion prevents cardiomyocyte apoptosis during ischemia/reperfusion6Subcellular redistribution of mitogen and stress activated kinase 1 (MSK1) contributes to protection against oxidative stress- induced apoptosis in cardiac myocytes7Excessive ROS production in mitochondria switches off protective mitochondrial kinase signaling

19. 878 PRE-CLINICAL CHARACTERISATION OF A NOVEL DIRECT ACTING ANTIVIRAL AGENT WITH A NEW MODE OF ACTION

20. Poster session 3

21. Poster session 2

23. Sunday, 18 July 2010

24. Structure of 4-(4-tert-Butylbenzyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4- yl)piperidin-4-amine bound to PKB

25. Structure of 4-Amino-N-(4-chlorobenzyl)-1-(7H-pyrrolo(2,3-d)pyrimidin- 4-yl)piperidine-4-carboxamide bound to PKB

28. Structure determination of Aurora Kinase in complex with inhibitor

29. Fragment-Based Discovery of the Pyrazol-4-yl urea (AT9283), a Multi- targeted Kinase Inhibitor with Potent Aurora Kinase Activity

36. P610 Akt-mediated cardioprotective effects of aldosterone in type 2 diabetic mice.

37. P598 Deleterious effects of cardiac aldosterone and exercise in type 2 diabetic mice.

38. P720 Notch3 is an important mediator of cardiac adaptation to pressure overload.

39. 162 Poster - Combined inhibition of SHP2 and ERK enhances anti-tumour effects in preclinical models.

40. A commentary on the use of pharmacoenhancers in the pharmaceutical industry and the implication for DMPK drug discovery strategies.

41. Discovery of ASTX029, A Clinical Candidate Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2.

42. Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein-Protein Interaction.

43. Mitochondrial 4-HNE derived from MAO-A promotes mitoCa 2+ overload in chronic postischemic cardiac remodeling.

44. Identification of a pharmacological inhibitor of Epac1 that protects the heart against acute and chronic models of cardiac stress.

45. Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2.

46. Beneficial effects of exercise training in heart failure are lost in male diabetic rats.

47. Imbalanced Angiogenesis in Peripartum Cardiomyopathy - Diagnostic Value of Placenta Growth Factor.

48. Multifunctional Mitochondrial Epac1 Controls Myocardial Cell Death.

49. Loss of Notch3 Signaling in Vascular Smooth Muscle Cells Promotes Severe Heart Failure Upon Hypertension.

50. Cyclic AMP Sensor EPAC Proteins and Their Role in Cardiovascular Function and Disease.

Catalog

Books, media, physical & digital resources